Skip to content

Evaluation of heart disease risk by using a calculated score among participants with sleep-related breathing disorder

Evaluation of cardiovascular risk in patients with obstructive sleep apnea using framingham risk score at a tertiary care center - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/03/105650
Enrollment
65
Registered
2026-03-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J399- Disease of upper respiratory tract, unspecified

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil Intervention4: Nil: Nil

Sponsors

Divya Kumawat
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Confirm diagnosis of obstructive sleep apnea (OSA) by polysomnography. 2.Those who give informed consent.

Exclusion criteria

Exclusion criteria: 1.History of any physician diagnosed CVD, such as MI, valvular heart disease and Coronary artery diseases (CAD) 2.Psychiatric disease. 3.Known central sleep apnea 4.Medication that may influence consciousness level and circadian rhythm. 5.Pregnancy and lactation.

Design outcomes

Primary

MeasureTime frame
To assess the 10-year cardiovascular risk in patients diagnosed with obstructive sleep apnea by applying the Framingham Risk Score. Timepoint: 6 months

Secondary

MeasureTime frame
1. To compare the cardiovascular risk profiles of OSA patients with different severity levels (mild, moderate, severe). 2. To identify cardiovascular risk factors that are most prevalent in the OSA patient population. 3. To evaluate the relationship between OSA severity (as measured by the Apnea-Hypopnea Index) and the calculated Framingham Risk Score. Timepoint: 6 months

Countries

India

Contacts

Public ContactDivya Kumawat

RUHS College of Medical Sciences Jaipur

sonalisharma14@gmail.com9414314678

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026